If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPEU.L Regulatory News (DPEU)

  • There is currently no data for DPEU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Offer from Jubilant Foodworks

28 Nov 2023 17:08

RNS Number : 9615U
DP Eurasia N.V
28 November 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

FOR IMMEDIATE RELEASE

28 November 2023

DP Eurasia N.V.

("DP Eurasia" or the "Company", and together with its subsidiaries, the "Group")

Response to Offer from Jubilant Foodworks

DP Eurasia (DPEU.L), the master franchisee of the Domino's Pizza brand in Turkey, Azerbaijan and Georgia, notes the announcement earlier today by Jubilant Foodworks Limited ("Jubilant Foodworks") of its intention to make an all cash offer for the entire issued and to be issued share capital of the Company not already owned by Jubilant Foodworks (the "Offer").

The Offer is both unsolicited and unexpected. For the time being, shareholders are advised to take no action. The Board is in the process of considering the Offer with its advisers and a further statement will be made in due course.

Enquiries

DP Eurasia N.V.

?lknur Kocaer, CFA - Investor Relations Director

+90 212 280 9636

Buchanan (Financial Communications)

Richard Oldworth / Toto Berger / Verity Parker

+44 20 7466 5000

dp@buchanan.uk.com

Liberum (Financial Adviser, Corporate Broker)

Corporate Broking: Andrew Godber / Edward Thomas / Will King

M&A: Tim Medak / Mark Harrison

+44 20 3100 2000

Important Notices

Liberum Capital Limited ("Liberum"), which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser exclusively for the Company and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters set out in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Liberum, nor for providing advice in relation to the contents of this announcement or any other matter referred to herein. Neither Liberum nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Liberum in connection with this announcement, any statement contained herein or otherwise. Neither Liberum nor any of its affiliates nor any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to, the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company.

This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this announcement or otherwise. The distribution of this announcement in jurisdictions other than the United Kingdom and the availability of any offer to shareholders of the Company who are not resident in the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore, any persons who are subject to the laws of any jurisdiction other than the United Kingdom or shareholders of the Company who are not resident in the United Kingdom will need to inform themselves about, and observe any applicable requirements.

Forward-looking statements

This document, including information included or incorporated by reference in this document, may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "targets", "believes", "estimates", "plans", "projects", "anticipates", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and involve predictions. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth or strategies and the industry in which it operates. Forward-looking statements speak only as of the date they are made and cannot be relied upon as a guide to future performance. There are many factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among such factors are changes in the global, political, social, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates, future business combinations or disposals, and any epidemic, pandemic or disease outbreak.

These forward-looking statements are based on numerous assumptions regarding the present and future business strategies of such persons and the environment in which each will operate in the future. By their nature, these forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this document may cause the actual results, performance or achievements of any such person, or industry results and developments, to be materially different from any results, performance or achievements expressed or implied by such forward-looking statements. No assurance can be given that such expectations will prove to have been correct and persons reading this document are therefore cautioned not to place undue reliance on these forward-looking statements that speak only as at the date of this document. All subsequent oral or written forward-looking statements attributable to the Company or its affiliates or any persons acting on its behalf are expressly qualified in their entirety by the cautionary statement above. The Company does not intend, nor undertakes any obligation, to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

No profit forecasts or estimates

Nothing in this announcement is intended or shall be deemed to be a forecast, projection or estimate of the future financial performance of the Company and no statement in this announcement should be interpreted to mean that earnings or earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for the Company.

Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 of the European Parliament and the Council of 16 April 2014 (and with respect to the United Kingdom, as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RSPDVLFLXFLBFBQ
Date   Source Headline
19th Sep 20231:41 pmRNSPDMR and PCA Notification
19th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotification of Interim Results
21st Aug 20237:00 amRNSUpdate on Russian Business
27th Jul 20237:00 amRNSTrading Update
25th Jul 20237:00 amRNSNotice of Trading Update
13th Jun 20232:00 pmRNSResults of 2022 Annual General Meeting
8th Jun 20237:00 amRNSIssue of Equity under the LTIP
31st May 20237:00 amRNSTrading Update
24th May 20237:00 amRNSNotice of Trading Update
9th May 20237:00 amRNSPDMR and PCA Notification
2nd May 202312:57 pmRNSIntended Appointment of INED
2nd May 202312:54 pmRNSNotice of 2023 Annual General Meeting
20th Apr 20237:00 amRNS2022 Annual Report and Accounts
12th Apr 20237:00 amRNSPreliminary Results
6th Apr 20232:07 pmRNSDirectorate Change
5th Apr 20237:00 amRNSNotification of Preliminary Results
9th Feb 20234:40 pmRNSSecond Price Monitoring Extn
9th Feb 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSFY22 Trading Update
28th Dec 20227:00 amRNSStatement in response to market speculation
23rd Nov 20227:00 amRNSTrading Update
15th Nov 20227:00 amRNSNotice of Trading Update
4th Oct 20221:55 pmRNSPDMR and PCA Notification
30th Sep 20227:00 amRNSInterim Results
20th Sep 20221:30 pmRNSResults of 2022 Extraordinary General Meeting
7th Sep 20227:00 amRNSIssue of Equity under the LTIP
30th Aug 202212:01 pmRNSPDMR and PCA Notification
23rd Aug 20229:58 amRNSPDMR and PCA Notification
22nd Aug 20227:00 amRNSNotification of Interim Results
8th Aug 20227:00 amRNSNotice of Extraordinary General Meeting
2nd Aug 20222:47 pmRNSPDMR and PCA Notification
21st Jul 20227:00 amRNSTrading Update
20th Jul 20225:07 pmRNSRecommended Appointment of INED
19th Jul 20228:53 amRNSPDMR and PCA Notification
15th Jul 20227:00 amRNSNotice of Trading Update
4th Jul 20222:45 pmRNSPDMR and PCA Notification
27th Jun 20222:48 pmRNSPDMR and PCA Notification
24th Jun 20223:36 pmRNSPDMR and PCA Notification
8th Jun 20222:00 pmRNSResults of 2022 Annual General Meeting
6th Jun 20227:00 amRNSPDMR and PCA Notification
30th May 20222:32 pmRNSPDMR and PCA Notification
26th May 20227:00 amRNSTrading Update
24th May 202210:22 amRNSPDMR and PCA Notification
23rd May 20227:00 amRNSNotice of Trading Update
17th May 202211:39 amRNSPDMR and PCA Notification
10th May 202212:44 pmRNSPDMR and PCA Notification
3rd May 20227:00 amRNSPDMR and PCA Notification
26th Apr 202212:00 pmRNSNotice of 2022 AGM and 2021 Annual Report
25th Apr 202211:00 amRNSPDMR and PCA Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.